Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cancer Pain 2Solid Tumor, Adult 1Medication Adherence 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Gastrointestinal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Colonic Neoplasms 1

Interventions

Surveys and Questionnaires 9Standard of Care 5Endoscopic Mucosal Resection 5Educational Status 5Blood Specimen Collection 5Diet Therapy 3Referral and Consultation 2Quality of Life 2Practice Guidelines as Topic 2Palliative Care 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Control Groups 2Aprepitant 2Acceptance and Commitment Therapy 2vandetanib 1fosaprepitant 1dolasetron 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Weights and Measures 1Tomography, X-Ray Computed 1Therapeutics 1Surgical Instruments 1Sunitinib 1Sorafenib 1Sampling Studies 1Restraint, Physical 1Remote Patient Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Gastrointestinal Neoplasms × Pharmaceutical Services × Clear all
NCT07063706 2025-07-18

Pharmaceutical Care for Patients Using Capecitabine

Faculdade de Farmácia

Phase NA Completed
176 enrolled
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡